NLRP3 and colorectal carcinoma: In a study conducted using colon cancer cell lines, it was discovered that metformin can suppress inflammatory factors’ expression, regulate the inflammatory microenvironment, and limit the progression of CRC by inhibiting the expression of the NLRP3 inflammasome [125].